Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL630634 | 0.68 | HDAC6 (0.41) | HDAC1HDAC6 | |
| Hydrochloric Acid SCHEMBL7988951 | 0.66 | HDAC6 (0.40) | HDAC1HDAC6 | |
| SCHEMBL366089 | 0.65 | HDAC1 (0.32) | HDAC1HDAC6 | |
| SCHEMBL7917255 | 0.64 | RAB9A (0.50) | — | |
| SCHEMBL6112612 | 0.64 | — | — | |
| SCHEMBL496792 | 0.64 | HDAC1 (0.31) | HDAC1HDAC6 | |
| SCHEMBL451027 | 0.62 | KDM4C (0.34) | HDAC1HDAC6 | |
| SCHEMBL3963993 | 0.62 | KDM4C (0.31) | HDAC1HDAC6 | |
| SCHEMBL5466824 | 0.61 | — | — | |
| SCHEMBL15987732 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117886714-A | Alanine derivative, preparation method and medical application thereof | 中国药科大学 | 2024-04-16 | — | — | CN | disclosed |
| US-8058305-B2 | Pyrrolidine derivatives as prostaglandin modulators | MERCK SERONO SA (CH) | 2011-11-15 | — | — | US | disclosed |
| US-20090292000-A1 | PYRROLIDINE DERIVATIVES AS PROSTAGLANDIN MODULATORS | LABORATOIRES SERONO S.A. (CH) | 2009-11-26 | — | — | US | disclosed |
| US-20060065537-A1 | Electrolytic copper plating solutions | BARSTAD LEON R | 2006-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090292000-A1 | PYRROLIDINE DERIVATIVES AS PROSTAGLANDIN MODULATORS | PGF, PTGIS, PDE5A | HDAC1 837/4885HDAC6 1725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.